Your browser doesn't support javascript.
loading
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study.
Hu, Yi; Xu, Xin; Liu, Xiao-Shun; He, Cong; Ouyang, Yao-Bin; Li, Nian-Shuang; Xie, Chuan; Peng, Chao; Zhu, Zhen-Hua; Xie, Yong; Shu, Xu; Zhu, Yin; Graham, David Y; Lu, Nong-Hua.
Afiliación
  • Hu Y; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Xu X; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
  • Liu XS; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • He C; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
  • Ouyang YB; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Li NS; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
  • Xie C; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Peng C; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
  • Zhu ZH; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Xie Y; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
  • Shu X; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Zhu Y; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
  • Graham DY; Department Of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Lu NH; JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi, China.
Front Immunol ; 13: 1049908, 2022.
Article en En | MEDLINE | ID: mdl-36726990

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China